The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes.
Shiuey EJ, Mehran NA, Ustaoglu M, Zhang Q, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D.
Shiuey EJ, et al.
Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):967-974. doi: 10.1007/s00417-021-05410-x. Epub 2021 Sep 22.
Graefes Arch Clin Exp Ophthalmol. 2022.
PMID: 34550421
PURPOSE: To evaluate the efficacy and safety profile of netarsudil 0.02% ophthalmic solution in a tertiary glaucoma referral center. METHODS: This retrospective cohort study included patients with glaucoma initiated on netarsudil 0.02% at a single institution from November …
PURPOSE: To evaluate the efficacy and safety profile of netarsudil 0.02% ophthalmic solution in a tertiary glaucoma referral center. …